1. The role of histamine in PAF-induced acute inflammatory responses (flare and weal) in the skin has been evaluated in a series of three separate studies. 2. Terfenadine, a potent H1-selective histamine antagonist virtually abolished the flare response and significantly inhibited the weal response. 3. Histamine depletion in the skin using compound 48/80 resulted in similar effects on the flare and weal response. Two consecutive daily injections of compound 48/80 were found to deplete comprehensively skin sites of histamine and the ability of skin to respond to PAF was completely restored within 2 weeks of compound 48/80 treatment. 4. Intradermally injected PAF was associated with acute rises in plasma histamine in blood drawn from a draining vein with peak concentrations occurring within 5 min of injection. 5. No difference in PAF-induced flare and weal response was found between atopic and non-atopic subjects and this was reflected in the peak plasma histamine results. A significantly higher baseline plasma histamine was found in the atopic group, however, when compared with the non atopic group. 6. It is concluded that histamine has an important role in the acute inflammatory responses to intradermally injected PAF, although there does appear to be a significant direct vascular component in the PAF-induced weal response.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1368497 | PMC |
| http://dx.doi.org/10.1111/j.1365-2125.1991.tb05617.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Attitudes and associated factors of patients' adoption of patient accessible electronic health records in China - A mixed methods study.
Digit Health
May 2023
School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Background: Although patient accessible electronic health records (PAEHRs) offer great potential in enhancing the provision of patient-centered care and improving satisfaction, the adoption rate is still low. Currently, few studies are there for researchers and health organization leaders to understand patients' thoughts and related factors of PAEHRs adoption in developing countries. China adopted more limited practices of PAEHRs, among which we selected Yuebei People's Hospital as an example.
View Article and Find Full Text PDFValidity of Skin Prick Test to Bermuda Grass in a desert environment.
Acta Biomed
September 2021
Al Rashed Allergy Center, Kuwait.
Article Synopsis
- The study aimed to validate the size of wheals from skin prick tests (SPT) to diagnose Bermuda grass allergies in adults living in desert environments.
- The research involved 53 adults who underwent SPT and a nasal challenge test to confirm allergy responses, with significant differences in wheal sizes observed in positive cases.
- The results suggested that a wheal size of ≥6.5 mm in SPT could reliably indicate Bermuda grass allergy, potentially reducing the need for more complex and less accessible testing methods in certain patients.
Effects of a topical treatment with spleen tyrosine kinase inhibitor in healthy subjects and patients with cold urticaria or chronic spontaneous urticaria: Results of a phase 1a/b randomised double-blind placebo-controlled study.
Br J Clin Pharmacol
December 2021
Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Aims: To explore the safety, tolerability, pharmacokinetics and pharmacodynamics (PD) of GSK2646264 using skin challenge models.
Methods: Healthy volunteers (HV) with a positive allergen skin prick test received GSK2646264 (0.5% or 1% ww) and placebo creams on up to 10% body surface area (BSA).
Cardiac safety of second-generation H -antihistamines when updosed in chronic spontaneous urticaria.
Clin Exp Allergy
December 2019
Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Article Synopsis
- Chronic urticaria symptoms are primarily triggered by histamine affecting H receptors on endothelial cells and sensory nerves, making second-generation antihistamines (sgAHs) the main treatment option.
- Some patients do not respond adequately to standard doses, prompting guidelines to recommend off-label updosing of sgAHs up to four times the licensed dose, placing safety responsibility on physicians.
- Concerns regarding safety, particularly cardiotoxicity, arise from past issues with early sgAHs, but a review of various sgAHs shows they maintain a strong safety profile with no cardiotoxic effects at higher doses if prescribers cautiously assess individual risk factors.
Rational ideation and empiric validation of an innovative digital dermographic tester.
Clin Exp Dermatol
April 2018
Department of Medicine, Surgery and Odontology Scuola Medica Salernitana, University of Salerno, Salerno, Italy.
Background: Dermographism is a condition characterized by a weal response to a combination of pressure and traction on skin surface, and its diagnosis is based on medical history, clinical criteria and provocation test. The Dermographic Tester , a pen-sized tool containing a spring-loaded blunt tip, is the most widely used instrument for the provocation test, and it exerts increasing pressures on the skin surface according to an arbitrary units (AU) scale. Analysing the mechanism of function and trying to convert the AUs to SI units (g/mm ), we found that this instrument had some defects and limits that would compromise a true and repeatable quantification of the weal response threshold.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!